Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2006 2
2007 1
2008 5
2009 7
2010 6
2011 9
2012 11
2013 15
2014 12
2015 15
2016 22
2017 6
2018 9
2019 10
2020 14
2021 13
2022 12
2023 14
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Nephrotic Syndrome: Genetics, Mechanism, and Therapies.
Shin JI, Kronbichler A, Oh J, Meijers B. Shin JI, et al. Among authors: meijers b. Biomed Res Int. 2018 Jan 28;2018:6215946. doi: 10.1155/2018/6215946. eCollection 2018. Biomed Res Int. 2018. PMID: 29670902 Free PMC article. No abstract available.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies.
Werion A, Storms P, Zizi Y, Beguin C, Bernards J, Cambier JF, Dahan K, Dierickx D, Godefroid N, Hilbert P, Lambert C, Levtchenko E, Meyskens T, Poiré X, van den Heuvel L, Claes KJ, Morelle J; UCLouvain TMA/HUS Network and KU Leuven TMA/HUS Network. Werion A, et al. Clin J Am Soc Nephrol. 2023 Jul 1;18(7):881-891. doi: 10.2215/CJN.0000000000000182. Epub 2023 Apr 21. Clin J Am Soc Nephrol. 2023. PMID: 37094330 Free PMC article.
Extracorporeal Techniques in Kidney Failure.
Meijers B, Vega A, Juillard L, Kawanishi H, Kirsch AH, Maduell F, Massy ZA, Mitra S, Vanholder R, Ronco C, Cozzolino M; Nomenclature Standardization Faculty. Meijers B, et al. Blood Purif. 2024;53(5):343-357. doi: 10.1159/000533258. Epub 2023 Sep 12. Blood Purif. 2024. PMID: 38109873 Free article.
The gut-kidney axis.
Evenepoel P, Poesen R, Meijers B. Evenepoel P, et al. Among authors: meijers b. Pediatr Nephrol. 2017 Nov;32(11):2005-2014. doi: 10.1007/s00467-016-3527-x. Epub 2016 Nov 15. Pediatr Nephrol. 2017. PMID: 27848096 Review.
The Evolving View of Uremic Toxicity.
Meijers B, Lowenstein J. Meijers B, et al. Toxins (Basel). 2022 Apr 12;14(4):274. doi: 10.3390/toxins14040274. Toxins (Basel). 2022. PMID: 35448883 Free PMC article. Review.
Food-Derived Uremic Toxins in Chronic Kidney Disease.
Lauriola M, Farré R, Evenepoel P, Overbeek SA, Meijers B. Lauriola M, et al. Among authors: meijers b. Toxins (Basel). 2023 Feb 1;15(2):116. doi: 10.3390/toxins15020116. Toxins (Basel). 2023. PMID: 36828430 Free PMC article. Review.
Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference.
Ostermann M, Ankawi G, Cantaluppi V, Madarasu R, Dolan K, Husain-Syed F, Kashani K, Mehta R, Prowle J, Reis T, Rimmelé T, Zarbock A, Kellum JA, Ronco C; Nomenclature Standardization Faculty. Ostermann M, et al. Blood Purif. 2024;53(5):358-372. doi: 10.1159/000533468. Epub 2023 Nov 3. Blood Purif. 2024. PMID: 38038238 Free article. Review.
172 results